Medical Biotechnology in India
- 30 June 2003
- book chapter
- Published by Springer Nature
- Vol. 85, 215-281
- https://doi.org/10.1007/3-540-36466-8_7
Abstract
The potential of biotechnology has just began to emerge in the 20th century. After the full knowledge of human genomes is available, biotechnology is going to play a major role in shaping the concept of future drug discovery, drug delivery, diagnostic methodology, clinical trials, and to a great extent the major lifestyle of the human society. This article is a comprehensive review of the major impact of biotechnology in diagnostics, antibiotics, r-proteins, vaccines, and antibodies production. It also highlights the future aspects of gene therapy in the management of healthcare. A comprehensive list of biotech products in healthcare management has been given. Also, the growth of biotechnology throughout the world at large and in the Indian industries in particular has been highlighted. Constraints, concerns and difficulties in biotechnology in India have been addressed mainly related to human resources, training institutions in India, funding in biotechnology, patent-related issues and regulatory hurdles. Like in information technology, India has great potential in bioinformatics as well. Some of the recent information on bioinformatics centers in India has been summarized. Indian biotechnology industries have the potential to use the modern discoveries in life sciences to reach an enviable position in the world of biotechnologyKeywords
This publication has 103 references indexed in Scilit:
- Affinity Maturation of Natural Antibody Using a Chain Shuffling Technique and the Expression of Recombinant Antibodies in Escherichia coliBiochemical and Biophysical Research Communications, 2000
- HIV Preventive VaccinesDrugs, 1995
- ErythropoeitinAnnual Review of Nutrition, 1995
- Thrombolytic Agents in DevelopmentDrugs, 1995
- InterleukinsDrugs, 1994
- The HIV Vaccine ParadoxScience, 1994
- Vaccine design: Future possibilities and potentialsBiotechnology Advances, 1994
- Yeast-derived recombinant human insulin-like growth factor I: Production, purification, and structural characterizationProtein Journal, 1990
- High-level expression, purification, and characterization of recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastorisBiochemistry, 1989
- Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin GImmunochemistry, 1971